Integrating traditional Chinese medicine into disease management in Singapore
Authors:
- 22 August 2025
- journal article
- review article
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 54 (8) , 491-497
Abstract
Introduction: While traditional Chinese medicine (TCM) has a long history and continues to be widely practised, its overall clinical efficacy according to conventional scientific standards remains the topic of ongoing research and exploration. This review focuses on the potential use of acupuncture and Chinese herbal medicine (CHM) in combination with Western medicine in Singapore, based on recently published data on the clinical effectiveness and cost-effectiveness of these TCM treatments. Method: We collated and summarised 71 research papers published in the past decade, focusing on randomised controlled trials, systematic reviews and population-based cohort studies that had a total sample size (treatment and control arms) exceeding 60. English-language articles published between 2015 and 2025 were identified by searching PubMed/MEDLINE, the Cochrane Library and the China National Knowledge Infrastructure. The search strategy included intervention terms like “acupuncture”, “Chinese medicine”, “TCM”, “traditional Chinese medicine”, “RCT” and “randomized controlled trial”; economic evaluation terms like “cost” and “cost-effectiveness”; and disease conditions of concern. We narrowed our research to the clinical effectiveness and cost-effectiveness of CHM in which either the individual ingredients or the products were listed as Chinese Proprietary Medicines (CPMs). Results: The summary tables demonstrate that the integration of acupuncture and/or CPMs with conventional Western medicine can enhance treatment outcomes across various chronic and non-chronic diseases. Their affordability and preventive focus can contribute to long-term healthcare cost savings, benefiting both patients and the healthcare system as a whole. Conclusion: With a robust regulatory framework, scientific validation and government support, acupuncture and CPMs have an important role in the management of various diseases, especially chronic ones, in Singapore.Keywords
This publication has 13 references indexed in Scilit:
- A multi-center cross-sectional study of Chinese Herbal Medicine-Drug adverse reactions using active surveillance in Singapore’s Traditional Chinese Medicine clinicsChinese Medicine, 2024
- Healthier SG: Singapore’s multi-year strategy to transform primary healthcareThe Lancet Regional Health - Western Pacific, 2023
- The societal cost of modifiable risk factors in SingaporeBMC Public Health, 2023
- Cost-Effectiveness Analysis of the TCM “Yupingfeng Granules” in the Treatment of Acute Exacerbations of COPD Based on a Randomized Clinical TrialInternational Journal of Chronic Obstructive Pulmonary Disease, 2022
- Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studiesBMJ Open, 2021
- Somatotopic Organization and Intensity Dependence in Driving Distinct NPY-Expressing Sympathetic Pathways by ElectroacupunctureNeuron, 2020
- Do acupuncture trials have lower risk of bias over the last five decades? A methodological study of 4 715 randomized controlled trialsPLOS ONE, 2020
- Economic burden of multimorbidity among older adults: impact on healthcare and societal costsBMC Health Services Research, 2016
- Regulatory control of Chinese Proprietary Medicines in SingaporeHealth Policy, 2005
- An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in SingaporeDrug Metabolism Reviews, 2005